Aquatic Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,086
Closed -$51.1K 1539
2025
Q1
$51.1K Buy
+6,086
New +$54.7K ﹤0.01% 1137
2024
Q2
Sell
-3,900
Closed -$50.9K 1599
2024
Q1
$50.9K Sell
3,900
-27,700
-88% -$369K ﹤0.01% 1021
2023
Q4
$403K Buy
31,600
+2,400
+8% +$24.2K 0.01% 685
2023
Q3
$383K Buy
29,200
+10,200
+54% +$187K 0.02% 540
2023
Q2
$486K Buy
19,000
+500
+3% +$12.9K 0.03% 457
2023
Q1
$466K Buy
18,500
+11,900
+180% +$279K 0.03% 427
2022
Q4
$151K Buy
+6,600
New +$152K 0.01% 799

Other funds holding TMCI

Aquatic Capital Management's TMCI Position: Q2 2025 in Review

Aquatic Capital Management sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 6,086 shares — an estimated $51.1K sold.

Aquatic Capital Management first reported a position in TMCI in Q4 2022 and held it in 7 quarters. The position peaked at $486K in Q2 2023. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Aquatic Capital Management reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 6,086 Treace Medical Concepts shares in Q2 2025, an estimated $51.1K.
  • Aquatic Capital Management first reported a position in Treace Medical Concepts in Q4 2022 and held it in 7 quarters.
  • Aquatic Capital Management's Treace Medical Concepts position peaked at $486K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Aquatic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.